ACTIVE

AstraZeneca

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result8,6 M €+5,6 %over 1 year

Revenue351,2 M €+10,6 %over 1 year

Equity46,9 M €+22,6 %over 1 year

Workforce234,4 ETP+5,7 %over 1 year

Identity

Source · BCE/KBO

AstraZeneca is a Public limited company incorporated in 1948. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Dilbeek. It employs on average 234,4 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0400.165.679
Incorporation: 28/11/1948
Legal form: Public limited company
Registered office: Alfons Gossetlaan 40 box 201
1702 Dilbeek · FlandreSee on map
Contributed capital: 26 583 725,34 €
Latest accounts: 31/12/2025
Average workforce: 234,4 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 51460Air transport

Joint committees (2)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 21 filings

Trend over 19 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	351,2 M €	+10.6%	317,5 M €	+13.9%	278,7 M €	+23.2%	226,1 M €	+31.3%	172,2 M €
EBITDA	12,1 M €	+36.9%	8,9 M €	-15.1%	10,4 M €	+38.5%	7,5 M €	+37.4%	5,5 M €
Operating result	12 M €	+35.6%	8,8 M €	-14.1%	10,3 M €	+37.6%	7,5 M €	+27.9%	5,8 M €
Net result	8,6 M €	+5.6%	8,2 M €	-10.1%	9,1 M €	+75.0%	5,2 M €	+33.8%	3,9 M €
Balance sheet
Equity	46,9 M €	+22.6%	38,2 M €	-39.4%	63 M €	+16.9%	53,9 M €	+10.7%	48,7 M €
Total assets	105,4 M €	+19.7%	88 M €	-6.5%	94,1 M €	-5.5%	99,6 M €	+10.0%	90,6 M €
Cash	1,5 M €	+96.1%	752,5 k €	-26.2%	1 M €	-19.0%	1,3 M €	+9.8%	1,1 M €
Debts	58,5 M €	+17.4%	49,8 M €	+60.3%	31,1 M €	-25.1%	41,5 M €	-0.6%	41,8 M €
Other
Workforce	234,4 ETP	+5.7%	221,7 ETP	+4.8%	211,5 ETP	+13.0%	187,2 ETP	+4.2%	179,6 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 18 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Angela Thompson	Managing director25/02/2025 → 26/05/2028
Jennifer Olivero	Director29/09/2021 → 26/05/2028
Luca Taliercio	Director01/01/2022 → 26/05/2028
Paul Van Mullem	Director01/06/2019 → 26/05/2028

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Keira Driansky	Managing director21/09/2022 → 2024 accounts
Nathalie Demeere	Director01/11/2019 → 2020 accounts
Anne-Laure Dreno	Managing director01/06/2019 → 2021 accounts

Other companies at this address

Alfons Gossetlaan 40 1702 Dilbeek

Company	CBE no.
Amplifon Belgium● Active	0418.975.266
Babel Music● Active	0413.046.586
CMP-LAW● Active	1017.596.019
CYCLE VALLEY● Active	0667.738.102
FOUNDATION AstraZeneca● Active	0452.299.023
Gus Foods● Active	0755.989.195
Intersong-Primavera, Editions Musicales● Active	0403.030.644
iwell Belgium● Active	1012.271.610
KarmaKarma● Active	0643.997.252
KatariComms● Active	0637.787.767
neeoo● Active	1042.011.315
neeoo Holding● Active	1042.008.642
WARNER CHAPPELL MUSIC BELGIUM● Active	0426.906.601
WARNER MUSIC BENELUX● Active	0417.118.905

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	17/06/2026	23/06/2025	17/07/2024	04/10/2023	24/06/2022	15/06/2021
General meeting	29/05/2026	30/05/2025	31/05/2024	26/05/2023	27/05/2022	28/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	29/05/2026	17/06/2026	Dutch	PDF
Full model	31/12/2024	30/05/2025	23/06/2025	Dutch	PDF
Full model	31/12/2023	31/05/2024	17/07/2024	Dutch	PDF
Full modelCorrection	31/12/2022	26/05/2023	04/10/2023	Dutch	PDF
Full model	31/12/2022	26/05/2023	21/06/2023	Dutch	PDF
Full model	31/12/2021	27/05/2022	24/06/2022	Dutch	PDF
Full model	31/12/2020	28/05/2021	15/06/2021	Dutch	PDF
Full model	31/12/2019	29/05/2020	31/07/2020	Dutch	PDF
Full model	31/12/2018	29/05/2019	11/07/2019	Dutch	PDF
Full model	31/12/2017	25/05/2018	05/06/2018	Dutch	PDF
Full model	31/12/2016	24/05/2017	26/06/2017	Dutch	PDF
Full model	31/12/2015	27/05/2016	06/06/2016	Dutch	PDF
Full model	31/12/2014	29/05/2015	09/06/2015	Dutch	PDF
Full model	31/12/2013	30/05/2014	17/06/2014	Dutch	PDF
Full model	31/12/2012	31/05/2013	24/06/2013	Dutch	PDF
Full model	31/12/2011	31/05/2012	25/06/2012	Dutch	PDF
Full model	31/12/2010	27/05/2011	17/06/2011	Dutch	PDF
Full model	31/12/2009	28/05/2010	29/06/2010	Dutch	PDF
Full model	31/12/2008	29/05/2009	26/06/2009	Dutch	PDF
Full model	31/12/2007	30/05/2008	24/06/2008	Dutch	PDF
Full model	31/12/2006	25/05/2007	22/06/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 18 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Angela Thompson	Managing director25/02/2025 → 26/05/2028
Jennifer Olivero	Director29/09/2021 → 26/05/2028
Luca Taliercio	Director01/01/2022 → 26/05/2028
Paul Van Mullem	Director01/06/2019 → 26/05/2028

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Keira Driansky	Managing director21/09/2022 → 2024 accounts
Nathalie Demeere	Director01/11/2019 → 2020 accounts
Anne-Laure Dreno	Managing director01/06/2019 → 2021 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates10/06/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates04/04/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates05/08/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates05/07/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates13/10/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates13/07/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/04/2022
ONTSLAGEN - BENOEMINGEN
PDF
Other03/11/2021
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation1948

Name

Registered office

Annual accounts

Filings19 filings

Mandates

Angela Thompson

Luca Taliercio

Paul Van Mullem

Jennifer Olivero

Keira Driansky

Nathalie Demeere

Anne-Laure Dreno

Lieve Wollaert

Leen Hofkens

Valerie Buyse

Hervé Dussart

Philippe Buée

Show the 10 other mandates

196619671968196919701971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028

AstraZeneca

Alfons Gossetlaan 40 bte 201, 1702 Groot-Bijgaarden

Managing director

Director

Managing director

Director

Managing director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Alfons Gossetlaan 40 bte 201, 1702 Groot-BijgaardenCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00174284

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
AstraZenecaCurrent	accounts 2007 → 2025	Accounts 2025 · 2026-00174284

Events

29/05/2026
nominationKPMG Bedrijfsrevisoren BV/KPMG Réviseurs d'Entreprises SRL · commissaris
2025
Annual accounts 20258,6 M €↑
25/02/2025
nominationAngela Thompson · gedelegeerd bestuurder
21/02/2025
nominationAngela Thompson · bestuurder
2024
Annual accounts 20248,2 M €↓
2023
Annual accounts 20239,1 M €↑
26/05/2023
reconductionPwC Bedrijfsrevisoren BV · commissaris
26/05/2023
nominationRomain Seffer · vertegenwoordiger van de commissaris
2022
Annual accounts 20225,2 M €↑
21/09/2022
demissionKeira Driansky · bestuurder en als persoon belast met het dagelijks bestuur
21/09/2022
nominationKeira Driansky · bestuurder
19/05/2022
reconductionAnne-Laure Dréno · bestuurder
19/05/2022
reconductionJennifer Olivero · bestuurder
19/05/2022
reconductionLuca Taliercio · bestuurder
19/05/2022
reconductionPaul Van Mullem · bestuurder
2021
Annual accounts 20213,9 M €↑
2020
Annual accounts 20203 M €↓
2019
Annual accounts 20193,1 M €↓
2018
Annual accounts 20183,8 M €↑
2017
Annual accounts 20172 M €↓
2016
Annual accounts 20163,1 M €↑
2015
Annual accounts 20151,8 M €↓
2014
Annual accounts 20146,7 M €↑
2013
Annual accounts 2013-4,5 M €↓
2012
Annual accounts 20125,3 M €↑
2011
Annual accounts 20111,9 M €↓
2010
Annual accounts 201019 M €↑
2009
Annual accounts 200916,9 M €↑
2008
Annual accounts 20082,8 M €↓
2007
Annual accounts 200715,6 M €
28/11/1948
IncorporationPublic limited company

AstraZeneca

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events